Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06802640Not ApplicableNot Yet Recruiting

Transcutaneous Spinal Cord Electrical Stimulation Combined With Kunming Locomotor Training for the Treatment of Spinal Cord Injury

Role: lead

NCT05967325Not ApplicableUnknown

SVF Combined With Functional Self-assembling Peptide Nanofiber Hydrogels in the Treatment of Spinal Cord Injury

Role: lead

NCT04034108Not ApplicableCompleted

Early Surgical Intervention Combined With Weight-supported Walking Training

Role: lead

NCT02663310Not ApplicableUnknown

Treatment for Chronic Spinal Cord Injury: Surgery With Rehabilitation vs Rehabilitation

Role: lead

All 4 trials loaded